Clinical biomarkers directing the management of patients with colon and lung cancer (beyond oncogene-addicted NSCLC)
Authors
Ioannis Ntanasis-Stathopoulos
Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece
Anastasios Kyriazoglou
Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece
Meletios A. Dimopoulos
Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece
Maria Gavriatopoulou
Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece
Language: English
Page range: 3 - 6
Submitted on: Aug 26, 2019
Accepted on: Nov 5, 2019
Published on: Sep 8, 2020
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2020 Ioannis Ntanasis-Stathopoulos, Anastasios Kyriazoglou, Meletios A. Dimopoulos, Maria Gavriatopoulou, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.